.jpg)
.png)
Case Presentation
A 15-year-old male was referred for dyslipidemia. Initial and follow-up laboratory findings are shown below. Renal and thyroid function were normal. No etiology was found for his elevated liver function tests (LFTs); liver ultrasound demonstrated only fatty infiltration.
Article By:
Pediatric Endocrinology and Diabetes
Cook Children’s Medical Center
Fort Worth, TX
Pediatric Endocrinology and Diabetes
Cook Children’s Medical Center
Fort Worth, TX
Diplomate, American Board of Clinical Lipidology
This year, Familial Hypercholesterolemia (FH) Awareness Day is on September 23, 2015. It was initiated by The FH Foundation as part of their mission to raise awareness of FH in the public.
There has been long-standing debate over the efficacy of statins in women for the primary prevention of cardiovascular disease (CVD), largely stemming from the under-enrollment of women in clinical trials.1 Here we summarize the data on use of statins in primary prevention of CVD in women and gender-specific management.
Article By:
Department of Medicine, Division of Cardiovascular Medicine
Columbus, Ohio
Diplomate, American Board of Clinical Lipidology
Department of Medicine, Division of Cardiovascular Medicine
Columbus, Ohio
A healthy lifestyle — consisting of no smoking, healthy eating, and physical activity — and adherence to prescribed risk-reducing medication are paramount to primary prevention of atherosclerotic cardiovascular disease (ASCVD).
Article By:
Park Nicollet Health System
St. Louis Park, MN
Diplomate, Accreditation Council for Clinical Lipidology
“An ounce of prevention is worth a pound of cure.” — Benjamin Franklin
Article By:
Professor of Medicine
McGill University
Montreal, Quebec
Diplomate, American Board of Clinical Lipidology
Medical Director, Chronic Disease Management
Wheaton Franciscan Medical Group
Racine, WI
Diplomate, American Board of Clinical Lipidology
Primary Prevention Often Comes too Late
Article By:
Rasmussen Cardiovascular Disease Prevention Center
University of Minnesota
Minneapolis, MN
Rasmussen Cardiovascular Disease Prevention Center
University of Minnesota
Minneapolis, MN
Dr. Underberg:
As a child growing up in the 60s and 70s, I remember many nights spent watching “The Carol Burnett Show.” Her song at the end of each show has always reminded me to take pleasure in things that have come and gone. I can think of no better way to title my last editors corner for LipidSpin.
Article By:
NYU School of Medicine & NYU Center for Prevention of Cardiovascular Disease
Director, Bellevue Hospital Lipid Clinic
New York, NY
Diplomate, American Board of Clinical Lipidology
Clinical Epidemiology & Biostatistics and Clinical Lipid Professor
Oklahoma University Health Sciences Center
Oklahoma City, OK
Diplomate, American Board of Clinical Lipidology
The Midwest Chapter was proud to be the host of the 2015 Scientific Sessions in Chicago. The meeting was well attended and very favorably reviewed, with an excellent faculty presenting talks both regarding novel research in clinical lipidology as well as practical applications of lipid management. Additionally, Drs.
Article By:
Medical Director, Chronic Disease Management
Wheaton Franciscan Medical Group
Racine, WI
Diplomate, American Board of Clinical Lipidology
As your new President, I first want to thank you for the opportunity to serve the National Lipid Association (NLA), and you, its members, for the 2015–2016 year. My colleague and good friend, Dr. Terry Jacobson, has been a tireless worker and advocate for the NLA in his role as president for the 2014–2015 year, and has been a tremendous role model for me. I promise to carry on Dr.
Article By:
Associate Professor of Medicine University of
Miami School of Medicine Miami, FL
Director, Lipid Clinic and Cardiovascular Risk Reduction Program
Diplomate, American Board of Clinical Lipidology
